全球數位化糖尿病管理市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

數位糖尿病管理市場預計將從 2025 年的 311.8 億美元成長到 2034 年的 1,016.2 億美元，2026 年至 2034 年的複合年成長率為 14.03%。

隨著數位醫療技術的蓬勃發展，全球數位糖尿病管理市場正迅速擴張。全球糖尿病患者數量的不斷成長，推動了對持續監測和管理工具的需求。行動應用程式、穿戴式裝置和連網血糖監測儀等工具，有助於提高患者參與治療的積極性，並改善治療效果。

智慧型手機和穿戴式健康設備的普及是主要促進因素。自疫情爆發以來，遠端醫療服務和遠端患者監護系統得到了廣泛應用。人們對自我護理和預防醫學的認知不斷提高，也促進了市場成長。此外，醫療服務提供者也正在採用數位化平台，以便更有效地追蹤病患資料。

展望未來，人工智慧 (AI) 和數據分析技術的進步預計將推動市場強勁成長。數位工具與醫療保健系統的整合有望改善個人化治療方案的發展。然而，對資料隱私的擔憂以及設備高成本可能會限制某些地區的普及應用。總體而言，醫療保健產業的數位轉型將支持其長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球數位化糖尿病管理市場：依產品與服務分類

• 市場分析、洞察與預測
• 設備（智慧血糖儀、持續血糖監測（CGM）系統、智慧胰島素筆、智慧胰島素幫浦/閉合迴路幫浦、智慧胰島素貼片）
• 應用程式（糖尿病/血糖值管理應用程式、肥胖/飲食管理應用程式）
• 資料管理軟體和平台
• 服務

第5章 全球數位糖尿病管理市場：依設備類型分類

• 市場分析、洞察與預測
• 手持裝置
• 穿戴式裝置

第6章 全球數位糖尿病管理市場：依最終用戶分類

• 市場分析、洞察與預測
• 自我/居家醫療保健
• 醫院及糖尿病專科診所
• 學術研究機構

第7章 全球數位糖尿病管理市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • B. Braun Melsungen AG
  • Dexcom Inc
  • Abbott Laboratories
  • F. Hoffmann-La Roche
  • Insulet Corporation
  • Tandem Diabetes Care
  • Ascensia Diabetes Care Holdings AG
  • LifeScan Inc
  • Tidepool
  • AgaMatrix
  • Glooko Inc

The Digital Diabetes Management Market size is expected to reach USD 101.62 Billion in 2034 from USD 31.18 Billion (2025) growing at a CAGR of 14.03% during 2026-2034.

The global digital diabetes management market has expanded rapidly with the growth of digital health technologies. Rising diabetes cases worldwide have increased the need for continuous monitoring and management tools. Mobile apps, wearable devices, and connected glucose monitors have improved patient engagement and treatment outcomes.

Major drivers include the increasing use of smartphones and wearable health devices. Telemedicine services and remote patient monitoring systems have gained popularity, especially after the pandemic. Growing awareness about self-care and preventive healthcare supports market growth. Healthcare providers are also adopting digital platforms to track patient data more effectively.

Looking ahead, the market is expected to grow strongly with advancements in artificial intelligence and data analytics. Integration of digital tools with healthcare systems will improve personalized treatment plans. However, data privacy concerns and high device costs may limit adoption in some regions. Overall, digital transformation in healthcare will support long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product & Service

• Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches)
• Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps)
• Data Management Software & Platforms
• Services

By Device Type

• Handheld Devices
• Wearable Devices

By End User

• Self/Home Healthcare
• Hospitals & Specialty Diabetes Clinics
• Academic & Research Institutes

COMPANIES PROFILED

• Medtronic, B Braun Melsungen AG, Dexcom Inc, Abbott Laboratories, F HoffmannLa Roche, Insulet Corporation, Tandem Diabetes Care, Ascensia Diabetes Care Holdings AG, LifeScan Inc, Tidepool, AgaMatrix, Glooko Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Devices (Smart Glucose Meters, Continuous Glucose Monitoring (Cgm) Systems, Smart Insulin Pens, Smart Insulin Pumps/Closed-Loop Pumps & Smart Insulin Patches) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Data Management Software & Platforms Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Device Type
• 5.2. Handheld Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Wearable Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Self/Home Healthcare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Hospitals & Specialty Diabetes Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIGITAL DIABETES MANAGEMENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product & Service
  • 7.2.2 By Device Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product & Service
  • 7.3.2 By Device Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product & Service
  • 7.4.2 By Device Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product & Service
  • 7.5.2 By Device Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product & Service
  • 7.6.2 By Device Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIGITAL DIABETES MANAGEMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 B. Braun Melsungen AG
  • 9.2.3 Dexcom Inc
  • 9.2.4 Abbott Laboratories
  • 9.2.5 F. Hoffmann-La Roche
  • 9.2.6 Insulet Corporation
  • 9.2.7 Tandem Diabetes Care
  • 9.2.8 Ascensia Diabetes Care Holdings AG
  • 9.2.9 LifeScan Inc
  • 9.2.10 Tidepool
  • 9.2.11 AgaMatrix
  • 9.2.12 Glooko Inc